查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1758046

全球血液黏度计市场

Blood Viscometers
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 275 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球血液黏度计市场规模将达到 46 亿美元

全球血液黏度计市场规模预计在2024年为34亿美元，预计到2030年将达到46亿美元，2024年至2030年的复合年增长率为4.9%。旋转黏度计产品是本报告分析的细分市场之一，预计其复合年增长率为4.0%，到分析期结束时将达到30亿美元。毛细管黏度计产品细分市场在分析期间的复合年增长率预计为6.8%。

美国市场规模将达 9.386 亿美元；中国市场预期复合年增长率为 7.7%

美国血液黏度计市场规模预计在2024年达到9.386亿美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到9.011亿美元，在2024-2030年的分析期内，复合年增长率为7.7%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为2.4%和4.9%。在欧洲，预计德国市场的复合年增长率为3.1%。

全球血液黏度计市场-主要趋势与驱动因素摘要

为什么血液黏度测量在心血管和血液学评估中具有越来越重要的临床意义？

随着越来越多的医疗相关人员认识到血液黏度作为心血管、代谢和血液系统疾病诊断和管理中关键生物标记的重要性，血液黏度计的临床应用也越来越广泛。血液黏度，即血液的稠度和黏稠度，在决定血管阻力和总循环效率方面起着关键作用。血液黏度升高与多种疾病有关，包括高血压、动脉粥状硬化、糖尿病、中风和周边动脉疾病。因此，临床医生将黏度测量纳入其常规诊断和风险分层方案中，尤其是针对老年人、糖尿病患者和慢性发炎性疾病患者等高风险族群。与仅关注胆固醇、血压和血糖水平的传统诊断方法不同，黏度计可以捕捉血液在不同剪切速率下的动态行为，从而提供更全面的血管健康状况图。这些测量对于了解可能先于重大心血管事件发生的微循环功能障碍和内皮压力尤其有价值。随着个人化医疗和预防医学的蓬勃发展，对血液黏度计等精准的即时诊断工具的需求日益增长。医院、研究机构和专科诊所越来越多地采用此类设备来改善诊断模型并优化治疗方案。在这个不断发展的医疗领域，血液黏度计已不再只是测试仪器，而逐渐成为实现精准心血管护理的重要工具。

技术创新如何提高血液黏度计的准确性和可及性？

黏度计技术的进步已将这些仪器转变为高度精密、易于使用的诊断工具，使其更易于应用于临床和研究。传统的黏度计需要大量的血液，并且涉及复杂的校准和手动操作，限制了其在专业实验室以外的应用。如今的血液黏度计整合了微流体系统、数位感测器和自动化分析软体，大大提高了易用性、速度和准确性。许多最新型号可以对一滴血液进行多次剪切速率测量，即时提供详细的流变曲线。热稳定性和机械稳定性的创新提高了测量的可重复性，而触控萤幕介面和无线连接则提高了易用性和数据完整性。这些技术改进实现了与电子健康记录(EMR) 的无缝连接，使临床医生能够将血液黏度作为慢性疾病管理的一部分进行长期监测。此外，微型可携式黏度计已被开发用于床边诊断、急救和行动医疗单元，扩大了其在分散式环境中的应用范围。人工智慧和机器学习也开始发挥作用，其演算法能够解读复杂的黏度模式，支援早期诊断和预测分析。随着经济高效、扩充性的解决方案越来越多，技术创新正在推动血液黏度计从诊断测试的边缘应用迈向主流临床工作流程，从而扩大其在更广泛的医疗保健环境中的效用。

多样化的临床应用如何扩大血液黏度计的市场机会？

血液黏度计在众多医学学科中的多功能性开启了巨大的市场潜力。在心臟病学中，它们用于评估血流动力学压力和血栓形成风险，为抗凝血剂和他汀类药物的使用提供重要数据。在内分泌学中，血液黏度测量有助于评估糖尿病和METABOLIC INC.症候群患者的微血管併发症。肿瘤学家使用黏度测定数据来监测某些骨髓恶性肿瘤（例如多发性骨髓瘤）患者的高黏度症候群。在神经病学中，血液黏度显示出评估中风风险和认知能力下降的潜力，尤其是在老年人群中。血液学家利用这些设备来诊断和监测红血球增多症、贫血和凝血障碍。此外，研究人员正在研究血液黏度在发炎和自体免疫疾病以及像 COVID-19 这样的感染疾病中的作用，高凝血状态已成为这些疾病的严重併发症。製药公司也在临床试验中使用血液黏度计来评估临床实验药物（尤其是针对血管系统的药物）的流变效应。这种广泛的应用正在推动医院、诊断实验室、学术机构和生技公司的需求。此外，运动医学和健康中心也开始采用黏度计来监测精英运动员的运动表现和心血管筛检。随着血液黏度作为关键健康指标的认可度不断提高，其在多学科护理模式中的应用正在迅速扩展，为製造商和医疗保健提供者开闢了新的成长途径。

哪些因素推动了血液黏度计市场的成长？

血液黏度计市场的成长受到医疗、技术、经济和人口等多种因素的共同驱动，这些因素反映了现代医疗保健重点的转变。其中一个主要驱动因素是全球心血管和代谢疾病负担的不断加重，这促使临床医生寻求更精准的诊断工具，而不仅仅是标准指标。随着文明病在已开发经济体和新兴经济体中日益普遍，对能够预测血管健康状况的早期检测工具的需求也日益增长。技术创新使这些设备变得更小、更实惠、更易于使用，从而促进了它们在小型诊所和分散式医疗机构中的部署。医疗保健系统越来越重视预防保健和基于价值的治疗结果，这与血液黏度计的早期诊断能力一致。强调全面心血管风险评估的监管支持和更新的临床指南进一步证明了血液黏度计在临床实践中的作用。同时，对医学研究和诊断基础设施的投资不断增加，尤其是在亚太地区和拉丁美洲，正在开拓新的市场并扩大其全球影响力。教育倡议和继续医学教育 (CME) 计画正在帮助临床医生了解血液黏度的重要性以及如何解读黏度数据，从而提高其使用率和可靠性。最后，黏度计与数位健康平台和数据分析工具的集成，正在提升效用。这些共同的驱动因素为血液黏度计市场在临床和商业领域的持续扩张奠定了坚实的基础。

部分

产品（旋转黏度计、毛细管黏度计）；最终用途（医院最终用途、诊断最终用途、其他最终用途）

受访公司范例（41家值得关注的公司）

  • A&D HOLON Holdings Co., Ltd.
  • AMETEK Inc.（Brookfield Engineering）
  • Anton Paar GmbH
  • ATAGO Co., Ltd.
  • Benson Viscometers Ltd.
  • BioFluid Technology Inc.
  • Cambridge Viscosity Inc.
  • Cannon Instrument Company
  • Fann Instrument Company
  • Grifols, SA
  • Haemonetics Corporation
  • Health Onvector
  • KYOTO ELECTRONICS MANUFACTURING CO., LTD.
  • LAUDA Scientific GmbH
  • Lamy Rheology
  • Microvisk Ltd.
  • PCE Instruments
  • Radiometer Medical ApS
  • RheoSense Inc.
  • Thermo Fisher Scientific Inc.

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP36402

Global Blood Viscometers Market to Reach US$4.6 Billion by 2030

The global market for Blood Viscometers estimated at US$3.4 Billion in the year 2024, is expected to reach US$4.6 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. Rotational Viscometers Product, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$3.0 Billion by the end of the analysis period. Growth in the Capillary Viscometers Product segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$938.6 Million While China is Forecast to Grow at 7.7% CAGR

The Blood Viscometers market in the U.S. is estimated at US$938.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$901.1 Million by the year 2030 trailing a CAGR of 7.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global Blood Viscometers Market - Key Trends & Drivers Summarized

Why Are Blood Viscometers Gaining Clinical Importance in Cardiovascular and Hemorheological Assessments?

Blood viscometers are gaining heightened clinical relevance as the healthcare community increasingly recognizes the importance of blood viscosity as a key biomarker in diagnosing and managing cardiovascular, metabolic, and hematologic conditions. Blood viscosity, or the thickness and stickiness of blood, plays a critical role in determining vascular resistance and overall circulatory efficiency. Elevated blood viscosity is linked to a range of disorders, including hypertension, atherosclerosis, diabetes, stroke, and peripheral artery disease. Consequently, clinicians are integrating viscometric assessments into routine diagnostics and risk stratification protocols, particularly for high-risk populations such as the elderly, diabetics, and patients with chronic inflammatory conditions. Unlike conventional diagnostics that often focus on cholesterol, blood pressure, or glucose levels alone, viscometers provide insight into the mechanical behavior of blood under various shear rates-offering a more holistic view of vascular health. These measurements are particularly valuable in understanding microcirculatory dysfunction and endothelial stress, which can precede major cardiovascular events. As personalized and preventive medicine gains momentum, the need for accurate, point-of-care tools like blood viscometers is intensifying. Hospitals, research institutions, and specialty clinics are increasingly adopting these devices to refine their diagnostic models and optimize treatment plans. In this evolving medical landscape, blood viscometers are emerging not just as laboratory tools but as critical enablers of precision cardiovascular care.

How Are Technological Innovations Enhancing the Accuracy and Accessibility of Blood Viscometers?

Advancements in viscometer technology are transforming these instruments into highly sophisticated and user-friendly diagnostic tools, making them more accessible for both clinical and research applications. Traditional viscometers required larger blood volumes, complex calibration, and manual operation, limiting their widespread use outside of specialized labs. Today’s blood viscometers incorporate microfluidic systems, digital sensors, and automated analysis software that significantly improve ease of use, speed, and precision. Many newer models can perform multiple shear rate measurements with a single drop of blood, offering detailed rheological profiles in real time. Innovations in thermal and mechanical stabilization have improved the reproducibility of results, while touchscreen interfaces and wireless connectivity enhance usability and data integration. These technological upgrades allow for seamless connection with electronic medical records (EMRs), enabling clinicians to monitor changes in blood viscosity over time as part of chronic disease management. Additionally, miniaturized and portable viscometers are being developed for bedside diagnostics, emergency care, and mobile health units, increasing their application scope in decentralized settings. Artificial intelligence and machine learning are also beginning to play a role, with algorithms capable of interpreting complex viscosity patterns to support early diagnosis and predictive analytics. As cost-effective and scalable solutions continue to emerge, technological innovation is pushing blood viscometers from the periphery of diagnostic testing into mainstream clinical workflows, expanding their utility across a growing range of healthcare environments.

How Are Diverse Clinical Applications Expanding Market Opportunities for Blood Viscometers?

The versatility of blood viscometers across a wide array of medical disciplines is significantly broadening their market potential. In cardiology, they are used to assess hemodynamic stress and thrombotic risk, providing vital data that can inform the use of anticoagulants and statins. In endocrinology, blood viscosity measurements help evaluate microvascular complications in patients with diabetes and metabolic syndrome. Oncologists use viscometric data to monitor hyperviscosity syndrome, which can occur in patients with certain hematologic malignancies such as multiple myeloma. In neurology, blood viscosity has shown potential in assessing stroke risk and cognitive decline, particularly among aging populations. Hematologists rely on these devices to diagnose and monitor polycythemia, anemia, and blood clotting disorders. Additionally, researchers are investigating the role of blood viscosity in inflammatory diseases, autoimmune conditions, and even infectious diseases like COVID-19, where hypercoagulability has emerged as a serious complication. Pharmaceutical companies are also using blood viscometers in clinical trials to evaluate the rheological effects of investigational drugs, particularly those targeting the vascular system. This wide range of applications is fueling demand in hospitals, diagnostic labs, academic institutions, and biotech firms. Moreover, sports medicine and wellness centers are beginning to adopt viscometers for performance monitoring and cardiovascular screening in elite athletes. As awareness of blood viscosity as a critical health metric grows, its integration into multidisciplinary care models is rapidly expanding, presenting new growth avenues for manufacturers and healthcare providers alike.

What Are the Key Drivers Behind the Growth of the Blood Viscometers Market?

The growth in the blood viscometers market is driven by a confluence of medical, technological, economic, and demographic factors that reflect the shifting priorities of modern healthcare. One of the primary drivers is the rising global burden of cardiovascular and metabolic diseases, which are prompting clinicians to seek more nuanced diagnostic tools beyond standard markers. As lifestyle diseases become more prevalent in both developed and emerging economies, there is a growing demand for early detection tools that can offer predictive insights into vascular health-something blood viscometers are uniquely positioned to deliver. Technological innovation has also made these devices more compact, affordable, and user-friendly, facilitating adoption in smaller clinics and decentralized care settings. Healthcare systems are increasingly prioritizing preventive care and value-based outcomes, both of which align with the early diagnostic capabilities of blood viscometers. Regulatory support and clinical guideline updates that emphasize comprehensive cardiovascular risk assessment are further legitimizing their role in practice. In parallel, increased investment in medical research and diagnostic infrastructure-particularly in Asia-Pacific and Latin America-is opening new markets and expanding global reach. Educational initiatives and continuing medical education (CME) programs are helping clinicians understand the significance of blood viscosity and how to interpret viscometric data, enhancing usage and trust. Lastly, the integration of viscometers with digital health platforms and data analytics tools is increasing their utility in longitudinal patient monitoring and chronic disease management. Together, these drivers are laying a strong foundation for the sustained expansion of the blood viscometers market in both clinical and commercial domains.

SCOPE OF STUDY:

The report analyzes the Blood Viscometers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Rotational Viscometers Product, Capillary Viscometers Product); End-Use (Hospitals End-Use, Diagnostics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • A&D HOLON Holdings Co., Ltd.
  • AMETEK Inc. (Brookfield Engineering)
  • Anton Paar GmbH
  • ATAGO Co., Ltd.
  • Benson Viscometers Ltd.
  • BioFluid Technology Inc.
  • Cambridge Viscosity Inc.
  • Cannon Instrument Company
  • Fann Instrument Company
  • Grifols, S.A.
  • Haemonetics Corporation
  • Health Onvector
  • KYOTO ELECTRONICS MANUFACTURING CO., LTD.
  • LAUDA Scientific GmbH
  • Lamy Rheology
  • Microvisk Ltd.
  • PCE Instruments
  • Radiometer Medical ApS
  • RheoSense Inc.
  • Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Blood Viscometers - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Focus on Hemorheology in Cardiovascular Risk Assessment Throws the Spotlight on Blood Viscometers
    • Growing Adoption in Clinical Diagnostics Spurs Demand for High-Precision Blood Viscosity Measurement Devices
    • Here's How Increased Awareness of Blood Flow Disorders Is Driving Use of Viscometers in Preventive Cardiology
    • Advancements in Point-of-Care Testing Technologies Expand the Accessibility of Bedside Viscosity Monitoring
    • Integration with Electronic Health Records and Smart Lab Systems Strengthens the Business Case for Digital Viscometers
    • Aging Population and Increased Prevalence of Hypertension and Diabetes Expand the Clinical Use of Blood Viscometry
    • Here's the Story: How Oncology and Critical Care Units Are Using Blood Viscometers to Monitor Treatment Impact
    • Surge in Research on Microcirculation and Thrombosis Supports Broader Application Across Specialty Clinics
    • Miniaturization and Automation Drive Innovation in Portable and User-Friendly Blood Viscometer Devices
    • Rising Demand from Pharmaceutical and Biotech Companies for Blood Rheology Data Fuels Use in Drug Trials
    • Global Expansion of Specialty Diagnostic Labs Creates New Market Opportunities for Advanced Viscometry Platforms
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Blood Viscometers Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Blood Viscometers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Blood Viscometers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Blood Viscometers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Rotational Viscometers Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Rotational Viscometers Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Rotational Viscometers Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Capillary Viscometers Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Capillary Viscometers Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Capillary Viscometers Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diagnostics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Diagnostics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Blood Viscometers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Blood Viscometers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Blood Viscometers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Blood Viscometers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Blood Viscometers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Blood Viscometers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Blood Viscometers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Blood Viscometers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Blood Viscometers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Blood Viscometers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Blood Viscometers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Blood Viscometers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Blood Viscometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Blood Viscometers by Product - Rotational Viscometers Product and Capillary Viscometers Product Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Blood Viscometers by Product - Percentage Breakdown of Value Sales for Rotational Viscometers Product and Capillary Viscometers Product for the Years 2014, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Blood Viscometers by End-Use - Hospitals End-Use, Diagnostics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Blood Viscometers by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostics End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION